Secondly, we the measured the expression of EDN3 after 5-Azacytidine (5-Aza), a DNMT1 inhibitor, treatment in cervical cancer cell lines to investigate the effect of methylation on EDN3 expression. The gene discussed is DNMT1; the disease is cervical cancer.